Retinoic acid receptor antagonist LE540 attenuates wakefulness via the dopamine D1 receptor in mice

scientific article published on 17 September 2011

Retinoic acid receptor antagonist LE540 attenuates wakefulness via the dopamine D1 receptor in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BRAINRES.2011.09.023
P698PubMed publication ID22000589

P2093author name stringSachiko Chikahisa
Koichi Shudo
Mika Shimizu
Madoka Nakagomi
Kazuyoshi Kitaoka
Kazuo Yoshizaki
Hiroyoshi Séi
Noriyuki Shimizu
P407language of work or nameEnglishQ1860
P921main subjecttretinoinQ29417
P304page(s)10-16
P577publication date2011-09-17
P1433published inBrain ResearchQ4955782
P1476titleRetinoic acid receptor antagonist LE540 attenuates wakefulness via the dopamine D1 receptor in mice
P478volume1423

Reverse relations

cites work (P2860)
Q36702269A systems approach identifies networks and genes linking sleep and stress: implications for neuropsychiatric disorders
Q45876277Chronic exposure to an extremely low-frequency magnetic field induces depression-like behavior and corticosterone secretion without enhancement of the hypothalamic-pituitary-adrenal axis in mice
Q34066233Serum nutritional biomarkers and their associations with sleep among US adults in recent national surveys
Q30506222Synergistic roles for G-protein γ3 and γ7 subtypes in seizure susceptibility as revealed in double knock-out mice
Q38770356Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.
Q38165261The rhythm of retinoids in the brain

Search more.